SCHEMBL4935664

SCHEMBL4935664

O=Cc1ccc(N2CCC(CN3CCCC3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.62
TRIM33 Q9UPN9 1/20 0.62
ALDH1A1 P00352 3/20 0.60
KDM4E B2RXH2 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
L3MBTL3 Q96JM7 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
CHRM5 P08912 1/20 0.42
ADRA2C P18825 1/20 0.42
MBTD1 Q05BQ5 1/20 0.40
TP53BP1 Q12888 1/20 0.40
CYP17A1 P05093 1/20 0.40
CYP21A2 P08686 1/20 0.40
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940737 0.83 L3MBTL3 (0.44) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL24267677 0.83 ALDH1A1 (0.44) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4940197 0.80 TRIM24 (0.58) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL24233918 0.79 MBTD1 (0.56) ALDH1A1KDM4EL3MBTL3L3MBTL1CHRM5
SCHEMBL12073558 0.78 L3MBTL1 (0.58) ALDH1A1KDM4ESMN1; SMN2L3MBTL3L3MBTL1
SCHEMBL4931385 0.78 L3MBTL3 (0.68) ALDH1A1KDM4EL3MBTL3L3MBTL1MBTD1
SCHEMBL12073571 0.78 CHRM5 (0.48) ALDH1A1L3MBTL3L3MBTL1CHRM5ADRA2C
SCHEMBL4941255 0.78 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL4939884 0.78 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2
SCHEMBL253732 0.78 TRIM24 (1.00) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
EP-1556046-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2005-07-27 EP disclosed
WO-2004037257-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines HRH2, HNMT, HRH3 TRIM24 4737/4885TRIM33 3990/4885ALDH1A1 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.